S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q3 2024

Avoro Capital Advisors

Period: Q3 2024 Β· Filed: 2024-11-14
View on SEC EDGAR β†—
AUM
$6.86B
Total portfolio value
Positions
36
Reported securities
Top Holding
UTHR
14.9% $1.02B
QoQ Changes
+1 / -6
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
UTHRUNITED THERAPEUTICS CORP$1.02B14.94%$358.35$555.91+55.1%
14.9%
ASNDASCENDIS PHARMA$744.9M10.86%$149.31$274.50+83.8%
10.9%
ARGXARGENX SE$671.4M9.79%$542.08$939.68+73.3%
9.8%
KRYSKRYSTAL BIOTECH INC$477.3M6.96%$182.03$375.07+106.0%
7.0%
MDGLMADRIGAL PHARMACEUTICALS INC$430.6M6.28%$212.22$528.10+148.8%
6.3%
APLSAPELLIS PHARMACEUTICALS INC.$320.4M4.67%$28.84β€”
4.7%
SRPTSAREPTA THERAPEUTICS INC$319.2M4.65%$124.89$19.28-84.6%
4.7%
RNAMAVIDITY BIOSCIENCES INC$315.8M4.60%β€”β€”
4.6%
FOLDAMICUS THERAPEUTICS INC.$247.5M3.61%β€”β€”
3.6%
ITCIINTRA-CELLULAR THERAPIES INC$223.2M3.25%β€”β€”
3.3%
XENEXENON PHARMACEUTICALS INC$223.1M3.25%$39.37$60.96+54.8%
3.3%
KYMRKYMERA THERAPEUTICS INC$213.0M3.11%$47.33$113.51+139.8%
3.1%
VERAVERA THERAPEUTICS INC$190.5M2.78%$44.20$41.20-6.8%
2.8%
ARWRARROWHEAD PHARMACEUTICALS INC.$172.2M2.51%$19.37$83.99+333.6%
2.5%
BMRNBIOMARIN PHARMACEUTICAL INC$143.3M2.09%$70.29$58.99-16.1%
2.1%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$139.7M2.04%$50.42$18.95-62.4%
2.0%
PCVXVAXCYTE INC$134.3M1.96%$114.27$58.39-48.9%
2.0%
SLNOSOLENO THERAPEUTICS INC$110.1M1.61%$50.49β€”
1.6%
BCRXBIOCRYST PHARMACEUTICALS INC$90.2M1.31%$7.60$9.84+29.5%
1.3%
SNDXSYNDAX PHARMACEUTICALS INC$74.8M1.09%$19.25$21.82+13.3%
1.1%
OCULOCULAR THERAPEUTIX INC$70.1M1.02%$8.70$9.64+10.8%
1.0%
KURAKURA ONCOLOGY INC$69.2M1.01%$19.54$11.10-43.2%
1.0%
MRUSMERUS N V$67.7M0.99%β€”β€”
1.0%
TRMLTOURMALINE BIO INC$57.1M0.83%β€”β€”
0.8%
MNKDMANNKIND CORP$55.0M0.80%$6.29$4.52-28.1%
0.8%
RAREULTRAGENYX PHARMACEUTICAL INC$46.1M0.67%$55.55$33.47-39.8%
0.7%
AUTLAUTOLUS THERAPEUTICS PLC$44.8M0.65%$3.63$1.58-56.5%
0.7%
IOVAIOVANCE BIOTHERAPEUTICS INC$39.8M0.58%$9.39$4.31-54.1%
0.6%
TSHATAYSHA GENE THERAPIES INC$37.5M0.55%$2.01$6.53+224.9%
0.6%
GLUEMONTE ROSA THERAPEUTICS INC$30.7M0.45%$5.30$24.21+356.8%
0.5%

Quarter-on-Quarter Activity

Q3 2024 vs. Q2 2024

New Positions (1)

TickerIssuerNotional
INSMED INC$0.1M

Exited Positions (6)

TickerIssuerNotional
CERECEREVEL THERAPEUTICS HLDNG$308.3M
XBISPDR SERIES TRUST - S&P BIOTECH$281.4M
ALNYALNYLAM PHARMCEUTICALS INC.$97.2M
VRCAVERRICA PHARMACEUTICALS INC$29.2M
BCYCBICYCLE THERAPEUTICS PLC$14.2M
ADVMADVERUM BIOTECHNOLOGIES INC$2.9M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
DYNDYNE THERAPEUTICS INC.$19.3M+461.6%
PCVXVAXCYTE INC$90.8M+104.3%-48.9%
GLUEMONTE ROSA THERAPEUTICS INC$13.7M+27.7%+356.8%
ASNDASCENDIS PHARMA$172.6M+18.9%+83.8%
KYMRKYMERA THERAPEUTICS INC$96.9M+15.7%+139.8%
KRYSKRYSTAL BIOTECH INC$30.5M+7.8%+106.0%
RNAMAVIDITY BIOSCIENCES INC$50.0M+5.7%
SLNOSOLENO THERAPEUTICS INC$24.8M+4.3%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
SYRESPYRE THERAPEUTICS INC$-25.6M-67.5%
IOVAIOVANCE BIOTHERAPEUTICS INC$-54.0M-63.8%-54.1%
BMRNBIOMARIN PHARMACEUTICAL INC$-232.0M-55.3%-16.1%
FOLDAMICUS THERAPEUTICS INC.$-24.3M-15.4%
SRPTSAREPTA THERAPEUTICS INC$-154.8M-14.8%-84.6%
BCRXBIOCRYST PHARMACEUTICALS INC$12.5M-5.6%+29.5%
MDGLMADRIGAL PHARMACEUTICALS INC$-145.3M-1.3%+148.8%
MNKDMANNKIND CORP$9.3M-0.1%-28.1%
← Back to Hedge Funds